The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

FDA Consumer: No Evidence Linking Cell Phone Use to Risk of Brain Tumors

May 18, 2010 5:36 am | by U.S. Food & Drug Administration | News | Comments

Although research is ongoing, the Food and Drug Administration (FDA) says that available scientific evidence - including World Health Organization (WHO) findings released May 17, 2010 - shows no increased health risk due to radiofrequency (RF) energy...

Gold Standard/Elsevier Offers Timely, Transparent, Reliable Drug Pricing Data, Including Average Wholesale Price (AWP)

May 18, 2010 4:40 am | by Bio-Medicine.Org | News | Comments

TAMPA, Florida , May 18, 2010 /- - Amidst Industry Unrest due to Drug Pricing Benchmark Upheaval, Gold Standard/Elsevier to Continue Publishing AWP and Other Pricing Standards Gold Standard/Elsevier, publisher of drug information databases and decision support solutions, has announced its...


Carefx to Collaborate with the Cleveland Clinic to Commercialize CCF Business Intelligence Solution

May 18, 2010 4:40 am | by Bio-Medicine.Org | News | Comments

SCOTTSDALE, Ariz. , May 18 /- Carefx Corp. , a leading provider of interoperable workflow solutions, announced today that it has been granted exclusive license rights to market and further develop the Cleveland Clinic business intelligence (BI) dashboards that are a part of IntellisEPM, a...


LensAR Laser System(TM) Receives FDA Clearance for Use in Cataract Surgery

May 18, 2010 4:40 am | by Bio-Medicine.Org | News | Comments

WINTER PARK, Fla. , May 18 /- LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced that the company has received 510(k) clearance from the FDA for use of the LensAR Laser System for anterior capsulotomy during...


FDA Approves Boston Scientific's Genesys HTAâ„¢ System

May 18, 2010 4:40 am | by Boston Scientific | News | Comments

Next-generation system strengthens Company's endometrial ablation portfolio for the treatment of menorrhagia


Well-tolerated radiotherapy provides longer life to patients with recurrent brain cancer

May 18, 2010 4:37 am | by EurekAlert | News | Comments

(Thomas Jefferson University) Patients who received hypofractionated stereotactic radiotherapy for their recurrent brain cancers lived longer lives, according to researchers at Thomas Jefferson University.


China Sky One Medical Announces First Quarter 2010 Results

May 18, 2010 4:37 am | by Bio-Medicine.Org | News | Comments

HARBIN, China , May 18 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced record...


Allied Healthcare approves $10 mln buyback plan

May 18, 2010 4:10 am | by The Associated Press | News | Comments

Allied Healthcare will buy back up to $10 million in its own shares, the company said Tuesday.The plan, approved by the board of directors, will use cash on hand and cash flow from operations. Allied had 45.1 million common shares outstanding as of Friday.Allied Healthcare International Inc.,...


Power from Glucose

May 17, 2010 11:36 pm | by Massachusetts Institute of Technology | News | Comments

An implanted biofuel cell may someday power medical devices.


Long-lasting sensory loss in WTC workers

May 17, 2010 9:36 pm | by EurekAlert | News | Comments

(Monell Chemical Senses Center) New research from the Monell Center and collaborating institutions reports that workers exposed to the complex mixture of toxic airborne chemicals following the 9/11 disaster had a decreased ability to detect odors and irritants two years after the exposure.


IBM 2010 Global CEO Study: Creativity Selected as Most Crucial Factor for Future Success

May 17, 2010 8:36 pm | by IBM | News | Comments

According to a major new IBM survey of more than 1,500 Chief Executive Officers from 60 countries and 33 industries worldwide, chief executives believe that -- more than rigor, management discipline, integrity or even vision -- successfully navigating an increasing complex world will...


Metronidazole injection 500 mg / 100 ml: Voluntary recall due to non-sterility

May 17, 2010 6:35 pm | by U.S. Food & Drug Administration | News | Comments

Non-sterility of metronidazole injection administered via the intravenous route has the potential to result in infections, which could be fatal.


Covidien Enters Hemorrhoidopexy Market with New Hemorrhoid Stapling Technology

May 17, 2010 5:36 pm | by Covidien | News | Comments

Stapler Innovation Addresses Current Challenges in Treating Rectal Prolapse and Hemorrhoid Disease NORTH HAVEN, Conn., May 17, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it is entering the hemorrhoidopexy market for...


Canadian National to buy back up to 3M shares

May 17, 2010 4:10 pm | by The Associated Press | News | Comments

Canadian National Railway Co. said Monday it will buy back up to 3 million shares through private deals with a third-party seller.The deal will be part of a 15 million-share repurchase program announced in January, the freight railroad said.Canadian National said it will negotiate the price...

World's biggest study on cell phones and brain cancer inconclusive

May 17, 2010 3:37 pm | by EurekAlert | News | Comments

(University of Montreal) The world's biggest investigation on possible links between cell-phone use and brain tumors is inconclusive, according to a Canadian scientist who collaborated on the Interphone International Study Group. Jack Siemiatycki, a professor at the University of...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.